You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 28, 2026

Production of Autologous Platelet-Rich Plasma for Boosting In Vitro Human Fibroblast Expansion
Published on: February 24, 2021
Knut Beitzel1, Mary Beth McCarthy2, Ryan P Russell2
1Department of Orthopaedic Sportsmedicine Technical University Munich, Germany.
In vitro cell models reveal that platelet-rich plasma (PRP) products vary, impacting musculoskeletal injury treatments. Understanding these variations is key to optimizing PRP therapy effectiveness and potentially reducing corticosteroid side effects.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: